News
FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...
The Food and Drug Administration is going all in on artificial intelligence. | The Food and Drug Administration is going all ...
The Food and Drug Administration on Thursday announced an aggressive agency-wide Artificial intelligence adoption timeline ...
WASHINGTON, D.C.—FDA Commissioner Martin Makary, M.D., offered more details into the agency’s recently announced plans to ...
The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...
Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...
GE HealthCare (Nasdaq: GEHC) today announced the launch of its CleaRecon DL technology for enhancing CBCT imaging.
The Food and Drug Administration plans to rapidly roll out a generative AI model to assist scientific ... encourage careful testing before full adoption. The announcement spurred many questions.
The U.S. Food and Drug Administration (FDA) recently announced it plans to phase out animal testing in the development of monoclonal ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results